Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Financial Data
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
-
31st Dec 17 Source: CRO
- €12.4 billion turnover
-
€3.5 billion
profit - 22,000 employees
- 10 more years available »
Ranking
By Turnover
(€13.7 billion)- 13th in Top Companies
- 2nd in Pharma
By Employees
(22,000)- 8th in Top Companies
- 1st in Pharma
-
- 22,000
- €13.7 billion
Employees
- Susan Hynes Vice President}
Latest News
- 9:36pm Kingspan manager belligerent over fire concerns in 2008, Grenfell inquiry hears
- 9:11pm Eurogroup reaches long-awaited deal on bailout fund reform
- 8:34pm Irish tech company Kastus agrees partnership with Lenovo
- 8:11pm Markets fall but still post biggest monthly gain on November’s vaccine joy
- 7:03pm McCaul chosen to lead MSD’s human health drug business in Ireland